Scorpius Holdings Inc (SCPX)
NYSEAMERICAN: SCPX · IEX Real-Time Price · USD
0.162
-0.002 (-1.10%)
At close: Mar 28, 2024, 4:00 PM
0.166
+0.004 (2.35%)
After-hours: Mar 28, 2024, 7:43 PM EDT
Company Description
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization.
The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies.
It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays.
The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024.
Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Scorpius Holdings Inc
Country | United States |
Founded | 2008 |
IPO Date | Jul 24, 2013 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 77 |
CEO | Jeffrey Wolf |
Contact Details
Address: 627 Davis Drive, Suite 400 Morrisville, North Carolina 27560 United States | |
Phone | 919-240-7133 |
Stock Details
Ticker Symbol | SCPX |
Exchange | NYSEAMERICAN |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001476963 |
Employer ID | 26-2844103 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Jeffrey Alan Wolf J.D. | Founder, Chairman of the Board, Chief Executive Officer and President |
William L. Ostrander | Chief Financial Officer and Secretary |
Dr. Justin Stebbing FRCP, FRCPath, M.A., M.D., Ph.D. | Chief Medical Advisor and Member of Scientific and Clinical Advisory Board |
Colonel George E. Peoples Jr., F.A.C.S., M.D. | Chief Medical Advisor |
Ania Szymanska | Head of Quality |
Joe Payne | President and Chief Operating Officer of Scorpius BioManufacturing |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 13, 2024 | 8-A12B/A | Filing |
Mar 13, 2024 | 8-K | Current Report |
Mar 11, 2024 | 8-K | Current Report |
Mar 11, 2024 | 424B5 | Filing |
Mar 7, 2024 | FWP | Free Writing Prospectus |
Mar 7, 2024 | 424B5 | Filing |
Mar 7, 2024 | 424B5 | Filing |
Mar 7, 2024 | 8-K | Current Report |
Feb 6, 2024 | 8-K | Current Report |
Jan 30, 2024 | 8-K | Current Report |